Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

AEye Reports Second Quarter 2023 Results

LIDR

AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high performance lidar solutions, today announced its results for the second quarter ended June 30, 2023.

Management Commentary

“AEye has taken a significant step forward this quarter in our path to commercialization in the automotive market,” said Matt Fisch, AEye CEO. “We’ve achieved major in-vehicle test milestones with three prestigious industry players, including NVIDIA and two global automotive OEMs; AEye has solidified a production-ready supply chain with Continental to deliver an ADAS product at a price well below $1,000; and we have been named a finalist for two automotive series production awards, with a strong pipeline of OEM RFQs representing a sizable revenue opportunity. Thanks to our capital-light licensing model and careful expense management, we accomplished these key milestones while reducing our cash burn rate. Looking ahead, we see momentum continuing to build throughout 2023 and beyond.”

Key Q2 2023 Financials

Overall, the cost reduction initiatives we implemented in the second quarter resulted in savings that exceeded our expectations and were an important driver in the improvement of our Q2 GAAP and non-GAAP net loss.

  • Revenue of $0.6 million in the second quarter of 2023.
  • GAAP net loss was $(16.0) million, or $(0.09) per share based on 175.7 million weighted average common shares outstanding.
  • Non-GAAP net loss was $(11.7) million, or $(0.07) per share based on 175.7 million weighted average common shares outstanding.
  • Cash, cash equivalents, and marketable securities were $58.7 million as of June 30, 2023.

Conference Call and Webcast Details

AEye management will hold a conference call today, August 7, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss these results. AEye CEO Matt Fisch and CFO Conor Tierney will host the call, followed by a question-and-answer session.

The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.

Access is also available via:

About AEye

AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Korea, and the United States.

Non-GAAP Financial Measures

The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to investors for a more consistent basis of comparison and to help investors evaluate the results of the Company’s on-going operations, and to help enable more meaningful period-to-period comparisons. Non-GAAP financial measures are presented only as supplemental information for the purpose of understanding the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.

This press release includes non-GAAP financial measures, including:

  • Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to the registration statements on Form S-1, plus change in fair value of convertible note and warrant liabilities, plus stock issuance costs, plus one-time termination benefits, plus impairment of ROU assets, and
  • Adjusted EBITDA which is defined as non-GAAP net loss plus depreciation and amortization expense, less interest expense and other, less interest income and other, plus provision for income tax expense.

Forward-Looking Statements

Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about the commercialization of AEye’s products, the achievement of certain milestones, the readiness of the supply chain, and AEye’s status with respect to certain automotive series production awards, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that AEye’s significant step forward in its path to commercialization in the automotive market may not result in the benefits anticipated, or if it does, in the time frame anticipated; (ii) the risks that AEye’s achievement of major in-vehicle test milestones may not result in the benefits anticipated, or if it does, in the time frame anticipated; (iii) the risks that the solidified production-ready supply chain with Continental may not result in the benefits anticipated, including the ability to deliver an ADAS product at a price well below $1,000, or if it does, in the time frame anticipated; (iv) the risks that AEye, despite being named a finalist for two automotive series production awards, may not be awarded one or both of the anticipated series production awards; (v) the risks that the strong pipeline of OEM RFQs, representing a sizable revenue opportunity, may not materialize in the time frame anticipated, or at all; (vi) the risks that the momentum may not continue to build throughout 2023 or beyond to the extent anticipated, or at all; (vii) the risks that AEye’s automotive-first strategy, capital-light model, and strategic partnership with Continental may not result in the anticipated opportunity for AEye to effectively capitalize on the market opportunity ahead, and such market opportunity, if any, may not be of the size AEye expected, materialize in the time frame anticipated, or create the anticipated value for our shareholders; (viii) the risks that AEye may fail to strengthen its competitive position or deliver on its key objectives due to supply chain disruptions, economic uncertainties, or otherwise; (ix) the risks that AEye’s products will not meet the diverse range of performance and functional requirements of AEye’s target markets and customers; (x) the risks that the size of the total available market for the use of lidar will be smaller than predicted or take longer to come to fruition than predicted; (xi) the risks that AEye may not continue to execute against its business plan to the extent anticipated, or at all; (xii) the risks that lidar adoption occurs slower than anticipated or fails to occur at all; (xiii) the risks that AEye is unable to adequately implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; and (xvi) the risks of economic downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by the lingering effects of the COVID-19 pandemic, which continues to cause significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the periodic report that AEye has most recently filed with the U.S. Securities and Exchange Commission, or the SEC, and other documents filed by us or that will be filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.

Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.

AEYE, INC.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
June 30, 2023 December 31, 2022
ASSETS
Current Assets:
Cash and cash equivalents $

18,392

$

19,064

Marketable securities

40,260

75,135

Accounts receivable, net

290

617

Inventories, net

4,913

4,553

Prepaid and other current assets

3,297

6,181

Total current assets

67,152

105,550

Right-of-use assets

14,749

15,502

Property and equipment, net

7,783

7,665

Restricted cash

-

2,150

Other noncurrent assets

6,235

2,473

Total assets $

95,919

$

133,340

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable $

3,520

$

3,218

Accrued expenses and other current liabilities

9,020

9,764

Contract liabilities

150

987

Convertible notes

1,641

8,594

Total current liabilities

14,331

22,563

Operating lease liabilities, noncurrent

15,888

16,681

Other noncurrent liabilities

44

126

Total liabilities

30,263

39,370

Stockholders' Equity:
Preferred stock

Common stock

18

16

Additional paid-in capital

358,833

345,742

Accumulated other comprehensive loss

(390

)

(1,279

)

Accumulated deficit

(292,805

)

(250,509

)

Total stockholders’ equity

65,656

93,970

Total liabilities and stockholders’ equity $

95,919

$

133,340

AEYE, INC.
Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)

Three months ended June 30,

Six months ended June 30,

2023

2022

2023

2022

Revenue:
Prototype sales $

245

$

195

$

370

$

530

Development contracts

326

511

837

1,258

Total revenue

571

706

1,207

1,788

Cost of revenue

1,911

1,427

4,172

2,909

Gross loss

(1,340

)

(721

)

(2,965

)

(1,121

)

Operating Expenses:
Research and development

5,897

10,762

15,339

19,338

Sales and marketing

2,604

5,323

8,872

9,939

General and administrative

6,345

9,827

14,899

21,157

Total operating expenses

14,846

25,912

39,110

50,434

Loss from operations

(16,186

)

(26,633

)

(42,075

)

(51,555

)

Other income (expense):
Change in fair value of convertible note and warrant liabilities

(116

)

141

(926

)

109

Interest income and other

301

350

578

774

Interest expense and other

(11

)

(307

)

165

(650

)

Total other income (expense), net

174

184

(183

)

233

Provision for income tax expense

19

18

38

26

Net loss $

(16,031

)

$

(26,467

)

$

(42,296

)

$

(51,348

)

Per Share Data
Net loss per common share (basic and diluted) $

(0.09

)

$

(0.17

)

$

(0.25

)

$

(0.33

)

Weighted average common shares outstanding (basic and diluted)

175,675,994

157,310,419

168,962,722

156,071,676

AEYE, INC.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Six months ended June 30,

2023

2022

Cash flows from operating activities:
Net loss $

(42,296

)

$

(51,348

)

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

666

463

Gain on sale of property and equipment, net

(52

)

Noncash lease expense relating to operating lease right-of-use assets

706

654

Impairment of right-of-use assets

47

Inventory write-downs, net of scrapped inventory

544

335

Change in fair value of convertible note and warrant liabilities

926

(109

)

Stock-based compensation

10,623

11,897

Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest

(65

)

826

Changes in operating assets and liabilities:
Accounts receivable, net

327

4,033

Inventories, current and noncurrent, net

(2,502

)

(1,316

)

Prepaid and other current assets

2,884

900

Other noncurrent assets

(2,164

)

411

Accounts payable

282

932

Accrued expenses and other current liabilities

(785

)

1,354

Operating lease liabilities

(749

)

(859

)

Contract liabilities

(837

)

(1,285

)

Net cash used in operating activities

(32,445

)

(33,112

)

Cash flows from investing activities:
Purchase of property and equipment

(808

)

(1,759

)

Proceeds from sale of property and equipment

96

Proceeds from redemptions and maturities of marketable securities

35,850

26,234

Net cash provided by investing activities

35,138

24,475

Cash flows from financing activities:
Proceeds from exercise of stock options

391

668

Taxes paid related to the net share settlement of equity awards

(1,051

)

(3,400

)

Payments for convertible note redemptions

(4,973

)

Proceeds from issuance of common stock under the Common Stock Purchase Agreement

1,422

Proceeds from issuance of common stock through Employee Share Purchase Plan

118

Net cash used in financing activities

(5,515

)

(1,310

)

Net increase (decrease) in cash, cash equivalents and restricted cash

(2,822

)

(9,947

)

Cash, cash equivalents and restricted cash at beginning of period

21,214

16,333

Cash, cash equivalents and restricted cash at end of period $

18,392

$

6,386

AEYE, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except share and per share data)
(Unaudited)

Three months ended June 30,

Six months ended June 30,

2023

2022

2023

2022

GAAP net loss $

(16,031

)

$

(26,467

)

$

(42,296

)

$

(51,348

)

Non-GAAP adjustments:
Stock-based compensation

4,110

6,557

10,623

11,897

Expenses related to registration statement on Form S-1s

250

250

Change in fair value of convertible note and warrant liabilities

116

(141

)

926

(109

)

Stock issuance costs

28

28

One-time termination benefits

45

1,298

Impairment of right-of-use assets

47

47

Non-GAAP net loss $

(11,713

)

$

(19,773

)

$

(29,402

)

$

(39,282

)

Depreciation and amortization expense

336

255

666

463

Interest income and other

(301

)

(350

)

(578

)

(774

)

Interest expense and other

(36

)

279

(212

)

622

Provision for income tax expense

19

18

38

26

Adjusted EBITDA $

(11,695

)

$

(19,571

)

$

(29,488

)

$

(38,945

)

GAAP net loss per share attributable to common stockholders:
Basic and diluted $

(0.09

)

$

(0.17

)

$

(0.25

)

$

(0.33

)

Non-GAAP net loss per share attributable to common stockholders:
Basic and diluted $

(0.07

)

$

(0.13

)

$

(0.17

)

$

(0.25

)

Shares used in computing GAAP net loss per share attributable to common stockholders:
Basic and diluted

175,675,994

157,310,419

168,962,722

156,071,676

Shares used in computing Non-GAAP net loss per share attributable to common stockholders:
Basic and diluted

175,675,994

157,310,419

168,962,722

156,071,676